PDF (6,0 MB) - Úrad priemyselného vlastníctva SR

VESTNÍK ÚRADU PRIEMYSELNÉHO VLASTNÍCTVA SR 2 - 2010 - SK (preklady patentov) 39
(86) PCT/EP2004/001981
(87) WO 2004/076422
(54) Spôsob prípravy solí 5-[(R)-2-(5,6-dietylindán-
-2-ylamino)-1-hydroxyetyl]-8-hydroxy-(1H)-chinolín-2-ónu,
ktoré sú užitočné ako agonisty
adrenoceptorov
(51) C07D 223/00, C07D 401/00, C07D 403/00,
C07D 409/00, C07D 417/00, A61K 31/55,
A61P 3/00, A61P 25/00
(11) E 6299
(96) 06802858.8, 1.9.2006
(97) 1924560, 5.8.2009
(24) 5.8.2009
(31) 713495 P
(32) 1.9.2005
(33) US
(73) ELI LILLY AND COMPANY, Indianapolis, IN, US;
(72) ALLEN John Gordon, Newbury Park, CA, US;
BRINER Karin, Indianapolis, IN, US; GALKA
Christopher Stanley, Carmel, IN, US; HOYING
Richard Charles, Plainfield, IN, US; MARTINEZ-
-GRAU Maria Angeles, Alcobendas, Madrid,
ES; MIYASHIRO Julie, Morton Grove, IL, US;
POKROVSKAIA Natalia, New Westminster, CA;
REINHARD Matthew Robert, Indianapolis, IN, US;
(74) Hörmannová Zuzana, Ing., Bratislava, SK;
(86) PCT/US2006/034334
(87) WO 2007/028082
(54) 6-Substituované 2,3,4,5-tetrahydro-1H-benzo-
[d]azepíny ako agonisty receptora 5-HT2C
(51) C07D 239/00, C07D 405/00, C07D 401/00,
C07D 417/00, C07D 409/00, C07D 221/00,
A61K 31/505, A61K 31/5355
(11) E 6261
(96) 03759708.5, 3.10.2003
(97) 1673354, 22.4.2009
(24) 22.4.2009
(73) Ortho-McNeil-Janssen Pharmaceuticals, Inc., Raritan,
NJ, US;
(72) HEINTZELMAN Geoffrey R., Annandale, NJ, US;
BULLINGTON James L., Hamilton Square, NJ, US;
RUPERT Kenneth C., South Orange, NJ, US;
(74) Bušová Eva, JUDr., Bratislava, SK;
(86) PCT/US2003/031471
(87) WO 2005/042500
(54) Arylíndenopyridíny a arylíndenopyrimidíny
a ich použitie ako antagonistov adenozínového
A2A receptora
(51) C07D 401/00, A61K 31/551, A61P 25/00
(11) E 6288
(96) 05741783.4, 23.3.2005
(97) 1732917, 29.7.2009
(24) 29.7.2009
(31) 102004015723
(32) 29.3.2004
(33) DE
(73) BOEHRINGER INGELHEIM INTERNATIO-
NAL GMBH, Ingelheim, DE;
(72) Mueller Stephan Georg, Warthausen, DE; Rudolf
Klaus, Warthausen, DE; Lustenberger Philipp,
Basel, CH; Stenkamp Dirk, Biberach, DE; Dreyer
Alexander, Gutenzell-Hürbel, DE; Arndt Kirsten,
Biberach, DE; Doods Henri, Warthausen, DE; Schaenzle
Gerhard, Biberach-Mettenberg, DE; Santagostino
Marco, Mittelbiberach, DE; Paleari Fabio,
Monza, IT;
(74) Čechvalová Dagmar, Bratislava, SK;
(86) PCT/EP2005/003094
(87) WO 2005/092880
(54) Vybrané CGRP-antagonisty, spôsob ich výroby
a ich použitie ako liečivá
(51) C07D 401/00, C07D 513/00, A61K 31/473,
A61P 27/00
(11) E 6286
(96) 06121714.7, 6.3.2003
(97) 1757601, 5.8.2009
(24) 5.8.2009
(31) 02005117
(32) 7.3.2002
(33) EP
(73) Novartis AG, Basel, CH;
(72) Gull Peter, Pfeffingen, CH; Pombo Villar Esteban,
Basel, CH;
(74) Čechvalová Dagmar, Bratislava, SK;
(54) Deriváty chinolínu a ich použitie pri glaukóme
a myopii
(51) C07D 405/00, C07D 307/00, C07C 69/00,
A61K 31/47, A61P 29/00
(11) E 6293
(96) 05808294.2, 11.11.2005
(97) 1844039, 15.7.2009
(24) 15.7.2009
(31) 102004055633, 102005020331
(32) 12.11.2004, 26.4.2005
(33) DE, DE
(73) Bayer Schering Pharma Aktiengesellschaft, Berlin,
DE;
(72) JAROCH Stefan, Berlin, DE; REHWINKEL Hartmut,
Berlin, DE; SCHÄCKE Heike, Berlin, DE;
SCHMEES Norbert, Berlin, DE; SKUBALLA
Werner, Berlin, DE; SCHNEIDER Matthias, Berlin,
DE; HÜBNER Jan, Berlin, DE; PETROV Orlin,
Berlin, DE; DINTER Christian, Berlin, DE;
(74) Čechvalová Dagmar, Bratislava, SK;
(86) PCT/EP2005/012531
(87) WO 2006/050998
(54) 5-substituované deriváty chinolínu a izochinolínu,
spôsob ich prípravy a ich použitie ako
protizápalové látky
(51) C07D 417/00, C07D 453/00, A61K 31/496
(11) E 6273
(96) 04742333.0, 24.3.2004
(97) 1606288, 3.6.2009
(24) 3.6.2009
(31) 0303602, 0304530
(32) 25.3.2003, 11.4.2003
(33) FR, FR
(73) LABORATOIRES FOURNIER SA, Dijon, FR;
(72) BARTH Martine, ASNIERES-LES-DIJON, FR;
BONDOUX Michel, FONTAINE-LES-DIJON,
FR; DODEY Pierre, FONTAINE-LES-DIJON, FR;
MASSARDIER Christine, DIJON, FR; THOMAS
Didier, SAINT-APOLLINAIRE, FR; LUCCARI-
NI Jean-Michel, DIJON, FR;